Scleroderma News and Research

Latest Scleroderma News and Research

Fibrosis in the liver stopped and reversed by researchers

University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed.

28 Dec 2007

New method for early diagnosis of pulmonary hypertension

Researchers at the University of Granada ( UGR ) from the Systemic Autoimmune Diseases Unit and the Cardiology Service of the Hospital Clínico San Cecilio in Granada have developed an innovative system which will help doctors make the earliest diagnosis of pulmonary hypertension possible, which is the main cause of death for patients suffering from scleroderma, a rare disease which affects approximately 1,200 out of every million people.

14 Nov 2007

Discovery on manipulating skin tone and color

In the timeless quest for healthier, younger looking skin, scientists from the University of Cincinnati and Tokyo Medical University have made an important discovery toward manipulating skin tone and color.

24 Aug 2007

Raynaud's disease review by Mayo Clinic Health Letter

There's a medical reason behind cold fingers and toes, when a chill seems to instantly turn extremities white.

10 May 2007

Green tea may help protect against Sjogren's syndrome

They found significantly less salivary gland damage in a group treated with green tea extract, suggesting a reduction of the Sjogren's symptom commonly referred to as dry mouth. Dry mouth can also be caused by certain drugs, radiation and other diseases.

20 Apr 2007

Rep. Dave Weldon comments on stem therapy and type I diabetes

In yet another advance in adult stem cell therapy, the Journal of the American Medical Association (JAMA) today released a study in which 14 of 15 Juvenile Diabetes patients demonstrated significant improvement as a result of an adult stem cell treatment.

11 Apr 2007

Atorvastatin may increase new blood vessel formation

Systemic sclerosis (SSc), also known as scleroderma, is an uncommon and confounding disease characterized by excessive fibrous tissue formation and vascular abnormalities.

6 Jun 2006

Antifibrotic effect of hepatocyte growth factor is impaired in lung fibroblasts isolated from African-Americans

Of the more than 40,000 persons who die each year in the U.S. from pulmonary fibrosis, the mortality rate among African-Americans is twice as high Caucasians.

11 Apr 2006

Paclitaxel may help treat scleroderma

Using a novel model for scleroderma, researchers from Duke University Medical Center have discovered two important insights into this devastating disorder - the anti-cancer drug paclitaxel (Taxol) may prevent the skin thickening and small blood vessel destruction that characterizes the disease.

1 Nov 2005

Cyclophosphamide may be a possible therapy for scleroderma

A drug that suppresses the immune system and reduces inflammation has been shown to be effective in treating lung disease associated with the devastating connective tissue disease scleroderma, according to results presented at the American Thoracic Society International Conference on May 23.

24 May 2005

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.

4 Dec 2004

African Americans more likely to carry genetic variants known to stimulate inflammatory response

Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).

1 Dec 2004

No convincing evidence that breast implants effect development of connective tissue disorders

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, found no convincing evidence that breast implants have an effect on the development of subsequent connective tissue disorders (CTDs).

19 Oct 2004

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

An investigational new drug for pulmonary hypertension may improve the quality of life for thousands of patients with scleroderma, lupus, and other associated connective tissue diseases, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas.

18 Oct 2004

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

More than 150,000 children in the United States are affected by rheumatic diseases such as juvenile rheumatoid arthritis, lupus, dermatomyositis, scleroderma, and systemic vasculitis.

10 Oct 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

Scleroderma News and Research

Latest Scleroderma News and Research

Fibrosis in the liver stopped and reversed by researchers

New method for early diagnosis of pulmonary hypertension

Discovery on manipulating skin tone and color

Raynaud's disease review by Mayo Clinic Health Letter

Green tea may help protect against Sjogren's syndrome

Rep. Dave Weldon comments on stem therapy and type I diabetes

Atorvastatin may increase new blood vessel formation

Antifibrotic effect of hepatocyte growth factor is impaired in lung fibroblasts isolated from African-Americans

Paclitaxel may help treat scleroderma

Cyclophosphamide may be a possible therapy for scleroderma

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

African Americans more likely to carry genetic variants known to stimulate inflammatory response

No convincing evidence that breast implants effect development of connective tissue disorders

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

Study on the long-term health effects associated with silicone breast implants

Designing a new treatment to treat migraine effectively

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

World Alzheimer’s Day 2022: Improving Post-Diagnosis Care with COGNISANCE

Scleroderma News and Research

Latest Scleroderma News and Research

Designing a new treatment to treat migraine effectively

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

World Alzheimer’s Day 2022: Improving Post-Diagnosis Care with COGNISANCE

Newsletters you may be interested in